186 related articles for article (PubMed ID: 36522438)
41. Evaluation of Intestinal Fibrosis with
Scharitzer M; Macher-Beer A; Mang T; Unger LW; Haug A; Reinisch W; Weber M; Nakuz T; Nics L; Hacker M; Bergmann M; Rasul S
Radiology; 2023 May; 307(3):e222389. PubMed ID: 36853176
[TBL] [Abstract][Full Text] [Related]
42. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
43. Biodistribution, pharmacokinetics, dosimetry of [
Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
[TBL] [Abstract][Full Text] [Related]
44. Head-To-Head Comparison of
Gege Z; Xueju W; Bin J
AJR Am J Roentgenol; 2023 Apr; 220(4):490-498. PubMed ID: 36321984
[No Abstract] [Full Text] [Related]
45. Impact of
Röhrich M; Naumann P; Giesel FL; Choyke PL; Staudinger F; Wefers A; Liew DP; Kratochwil C; Rathke H; Liermann J; Herfarth K; Jäger D; Debus J; Haberkorn U; Lang M; Koerber SA
J Nucl Med; 2021 Jun; 62(6):779-786. PubMed ID: 33097632
[TBL] [Abstract][Full Text] [Related]
46. Fibroblast Activation Protein-Targeted PET/CT with
Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F
J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902
[TBL] [Abstract][Full Text] [Related]
47. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract][Full Text] [Related]
48. [
Conen P; Pennetta F; Dendl K; Hertel F; Vogg A; Haberkorn U; Giesel FL; Mottaghy FM
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3365-3372. PubMed ID: 34988624
[TBL] [Abstract][Full Text] [Related]
49. Prospective Comparison of
Lan L; Zhang S; Xu T; Liu H; Wang W; Feng Y; Wang L; Chen Y; Qiu L
Radiology; 2022 Sep; 304(3):648-657. PubMed ID: 35579524
[TBL] [Abstract][Full Text] [Related]
50. Comparison of
Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
[TBL] [Abstract][Full Text] [Related]
51.
Zhao L; Chen S; Chen S; Pang Y; Dai Y; Hu S; Lin L; Fu L; Sun L; Wu H; Chen H; Lin Q
Radiother Oncol; 2021 May; 158():55-61. PubMed ID: 33621587
[TBL] [Abstract][Full Text] [Related]
52. [
Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
[TBL] [Abstract][Full Text] [Related]
53. Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management.
Qin C; Song Y; Gai Y; Ruan W; Liu Q; Liu F; Zheng D; Zhang P; Liu H; Zhang T; Tao K; Lan X
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4228-4240. PubMed ID: 35657428
[TBL] [Abstract][Full Text] [Related]
54. FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature Cells.
Hotta M; Mona CE; Crompton JG; Armstrong WR; Gafita A; Nelson SD; Eilber FC; Dawson DW; Calais J; Benz MR
Clin Nucl Med; 2023 Jul; 48(7):e353-e355. PubMed ID: 37146173
[TBL] [Abstract][Full Text] [Related]
55. The Added Value of
Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
[No Abstract] [Full Text] [Related]
56. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H
Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335
[TBL] [Abstract][Full Text] [Related]
57. Enhanced Detection of Early Pulmonary Fibrosis Disease Using
Chen J; Luo D; Dai Y; Zhou Y; Pang Y; Wu H; Sun L; Su G; Lin Q; Zhao L; Chen H
Mol Pharm; 2024 Jul; 21(7):3684-3692. PubMed ID: 38899595
[TBL] [Abstract][Full Text] [Related]
58. Comparison of
Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
[TBL] [Abstract][Full Text] [Related]
59. Visualization of fibroblast activation using
Kupusovic J; Kessler L; Bruns F; Bohnen JE; Nekolla SG; Weber MM; Lauenroth A; Rattka M; Hermann K; Dobrev D; Rassaf T; Wakili R; Rischpler C; Siebermair J
J Nucl Cardiol; 2023 Oct; 30(5):2018-2028. PubMed ID: 36944827
[TBL] [Abstract][Full Text] [Related]
60. FAPI-74 PET/CT Using Either
Giesel FL; Adeberg S; Syed M; Lindner T; Jiménez-Franco LD; Mavriopoulou E; Staudinger F; Tonndorf-Martini E; Regnery S; Rieken S; El Shafie R; Röhrich M; Flechsig P; Kluge A; Altmann A; Debus J; Haberkorn U; Kratochwil C
J Nucl Med; 2021 Feb; 62(2):201-207. PubMed ID: 32591493
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
